Vericel (VCEL) EBT Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,297.00 |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | 893.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 893.00 |
| Dec 31, 2025 | 1,341.00 |
| Sep 30, 2025 | 2,456.00 |
| Jun 30, 2025 | 2,336.00 |
| Mar 31, 2025 | -168.00 |
| Dec 31, 2024 | 1,763.00 |
| Sep 30, 2024 | 1,273.00 |
| Jun 30, 2024 | 52.00 |
| Mar 31, 2024 | 184.00 |
| Dec 31, 2023 | -573.00 |
| Sep 30, 2023 | -1,987.00 |
| Jun 30, 2023 | 3,040.00 |
| Mar 31, 2023 | -61.00 |
| Dec 31, 2022 | -1,162.00 |
| Sep 30, 2022 | -2,842.00 |
| Jun 30, 2022 | 5,142.00 |
| Mar 31, 2022 | -657.00 |
| Dec 31, 2021 | -1,608.00 |
| Sep 30, 2021 | -767.00 |
| Jun 30, 2021 | 1,486.00 |
| Mar 31, 2021 | 1,702.00 |
| Dec 31, 2020 | 1,891.00 |
| Sep 30, 2020 | 4,169.00 |
| Jun 30, 2020 | -2,470.00 |
| Mar 31, 2020 | 8,795.00 |
| Dec 31, 2019 | 1,876.00 |
| Sep 30, 2019 | 7,057.00 |
| Jun 30, 2019 | -3,674.00 |
| Mar 31, 2019 | 90.00 |
| Dec 31, 2018 | 5,705.00 |
| Sep 30, 2018 | 3,646.00 |
| Jun 30, 2018 | -764.00 |
| Mar 31, 2018 | 1,567.00 |
| Dec 31, 2017 | 2,436.00 |
| Sep 30, 2017 | 5,256.00 |
| Jun 30, 2017 | 17,562.00 |
| Dec 31, 2016 | 6.15 Mn |
| Jun 30, 2016 | 17.44 Mn |
| Mar 31, 2016 | 8.95 Mn |
| Dec 31, 2015 | 4.00 Mn |
| Mar 31, 2015 | 42.77 Mn |
| Sep 30, 2014 | 8.25 Mn |